TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nord Vacc Läkemedel AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
663
|
580
|
454 |
Financial expenses |
9
|
1
|
3 |
Earnings before taxes |
-923
|
-67
|
-299 |
EBITDA |
-910
|
-92
|
-281 |
Total assets |
460
|
769
|
478 |
Current assets |
456
|
614
|
300 |
Current liabilities |
166
|
129
|
320 |
Equity capital |
29
|
51
|
55 |
- share capital |
42
![]() |
42
|
46 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
6.3%
|
6.6%
|
11.5% |
Turnover per employee |
332
|
193
|
151 |
Profit as a percentage of turnover |
-139.2%
|
-11.6%
|
-65.9% |
Return on assets (ROA) |
-198.7%
|
-8.6%
|
-61.9% |
Current ratio |
274.7%
|
476.0%
|
93.8% |
Return on equity (ROE) |
-3182.8%
|
-131.4%
|
-543.6% |
Change turnover |
82
|
162
|
83 |
Change turnover % |
14%
|
39%
|
22% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.